Equivet TZ
Brand names,
Equivet TZ
Analogs
Equivet TZ
Brand Names Mixture
Equivet TZ
Chemical_Formula
C11H16N2O
Equivet TZ
RX_link
http://www.rxlist.com/cgi/generic3/tocainide.htm
Equivet TZ
fda sheet
Equivet TZ
msds (material safety sheet)
Equivet TZ
Synthesis Reference
No information avaliable
Equivet TZ
Molecular Weight
192.258 g/mol
Equivet TZ
Melting Point
246-266 oC
Equivet TZ
H2O Solubility
1.07E+004 mg/L
Equivet TZ
State
Solid
Equivet TZ
LogP
1.308
Equivet TZ
Dosage Forms
400 mg and 600 mg tablets for oral administration
Equivet TZ
Indication
For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening.
Equivet TZ
Pharmacology
Tocainide is a primary amine analog of lidocaine with antiarrhythmic properties useful in the treatment of ventricular arrhythmias. Tocainide, like lidocaine, produces dose dependent decreases in sodium and potassium conductance, thereby decreasing the excitability of myocardial cells. In experimental animal models, the dose-related depression of sodium current is more pronounced in ischemic tissue than in normal tissue. Tocainide is a Class I antiarrhythmic compound with electrophysiologic properties in man similar to those of lidocaine, but dissimilar from quinidine, procainamide, and disopyramide.
Equivet TZ
Absorption
Following oral administration, the bioavailability approaches 100 percent, and is unaffected by food.
Equivet TZ
side effects and Toxicity
The oral LD50 of tocainide was calculated to be about 800 mg/kg in mice, 1000 mg/kg in rats, and 230 mg/kg in guinea pigs; deaths were usually preceded by convulsions.
Equivet TZ
Patient Information
Equivet TZ
Organisms Affected
Humans and other mammals